Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 5;20(6):e0319141.
doi: 10.1371/journal.pone.0319141. eCollection 2025.

Understanding motivations of older women to continue or discontinue breast cancer screening

Affiliations

Understanding motivations of older women to continue or discontinue breast cancer screening

Susan C Weller et al. PLoS One. .

Abstract

Breast cancer screening guidelines indicate screening in women over 75 years of age is optional, depending upon patient health and preferences. To better understand the preferences and decision-making of older women, their experiences and perceptions concerning screening need to be linked to their intention to continue or discontinue screening. This study used a qualitative comparative analysis to identify the characteristics and themes linked to the intention to continue or discontinue screening. To capture the range of experiences and preferences, a purposive sample of community-residing adults (n = 59) was selected with equal representation of White, Black, and Hispanic women by age (70-74 years and 75 and older) and educational level (≤12 grade and >12 grade). In-depth qualitative interviews explored women's perceptions of mammograms, the benefits and risks of screening, and personal screening experiences. Interviews were coded and quality-checked by two or more coders. A qualitative comparative analysis (QCA) identified combinations of personal characteristics and themes linked to the intention to continue (n = 32) or discontinue (n = 27) screening. Results indicated personal experiences were strongly linked to the intention to continue or discontinue. Women who mentioned recent screening (within three years) and either a spontaneously mentioned cancer story concerning a friend or family member or a doctor's screening recommendation intended to continue screening (91% true positive rate, model sensitivity). Women who did not schedule screening and who did not mention a cancer story or a doctor's recommendation (or neither) intended to discontinue screening (81% true negative rate, model specificity). These experiences transcended differences in race/ethnicity, age, and educational level. Continuation of breast cancer screening in older women is motivated by their personal screening history combined with cancer experiences and/or a doctor's screening recommendation.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Update of

Similar articles

References

    1. US Preventive Services Task Force, Nicholson WK, Silverstein M, Wong JB, Barry MJ, Chelmow D, et al.. Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2024;331(22):1918–30. doi: 10.1001/jama.2024.5534 - DOI - PubMed
    1. Oeffinger KC, Fontham ETH, Etzioni R, Herzig A, Michaelson JS, Shih Y-CT, et al.. Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. JAMA. 2015;314(15):1599–614. doi: 10.1001/jama.2015.12783 - DOI - PMC - PubMed
    1. American Cancer Society. American Cancer Society Recommendations for the Early Detection of Breast Cancer. https://www.cancer.org/cancer/types/breast-cancer/screening-tests-and-ea...
    1. Practice Bulletin Number 179: Breast Cancer Risk Assessment and Screening in Average-Risk Women. Obstet Gynecol. 2017;130(1):e1–16. doi: 10.1097/AOG.0000000000002158 - DOI - PubMed
    1. Welch HG, Prorok PC, O’Malley AJ, Kramer BS. Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness. N Engl J Med. 2016;375(15):1438–47. doi: 10.1056/NEJMoa1600249 - DOI - PubMed